:: Volume 24, Issue 5 (Sep and Oct 2022) ::
Koomesh 2022, 24(5): 567-569 Back to browse issues page
Whole-inactivated SARS-CoV-2 vaccines: from fear to hope
Somayeh Shatizadeh Malekshahi , Alireza Tahamtan , Vahid Salimi
Abstract:   (858 Views)
Undoubtedly, vaccination can be one of the promising approaches to control infectious diseases such as the COVID-19 pandemic. Inactivated viral vaccines have a history of "vaccine-induced enhanced disease", which may occur when neutralizing antibodies bind to viral antigens without blocking or clearing the infection. This can cause additional inflammation through the mechanisms described for other respiratory pathogens and lead to acute respiratory distress syndrome. Since the structure and function of SARS-CoV-2 glycoproteins are well known, vaccine manufacturers appear to be careful when inactivating the virus to completely inactivate and maintain the viral epitopes necessary for protective immune induction. It seems that caution should be taken in the usage of inactivated vaccines in children to ensure they are safe and efficacious, vaccinated children should be well monitored and any symptoms should be reported immediately.
Keywords: COVID-19, SARS-CoV-2, Inactivated Vaccine
Full-Text [PDF 439 kb]   (593 Downloads)    
Type of Study: Research | Subject: General
Received: 2021/12/1 | Accepted: 2022/02/5 | Published: 2022/12/19


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 5 (Sep and Oct 2022) Back to browse issues page